Drug related Iatrogenic disease: the specal vulnerability of children

Show simple item record

dc.contributor.author Ranganathan, Shilani Sri
dc.date.accessioned 2021-07-30T06:48:01Z
dc.date.available 2021-07-30T06:48:01Z
dc.date.issued 2001
dc.identifier.citation Ranganathan, S. S. (2001). Drug related Iatrogenic disease: the specal vulnerability of children. en_US
dc.identifier.uri http://archive.cmb.ac.lk:8080/xmlui/handle/70130/5613
dc.description.abstract Only about 2500 people will have been exposed to a drug before it is marketed and the chance of finding an adverse reaction with an incidence oF less than 1 /1000 prior to marketing is therefore small. . Drugs may not be extensively tested in children so that many medicines given to children are not licensed for a particular indication' age of the child, or presented in a suitable formulation or route of administration . The use of'off label' or unlicensed drugs to treat children is widespread throughout Europe so that continued monitoring is essential to detect the adverse drug reacdons in children' . The Yellow Card Scheme is an important mechanism for doctors and pharmacists to rePort their suspicions about a possible adverse drug reaction and allow early detection of an adverse effect. . Early detection and reporting of suspected adverse drug reactions by doctors caring for children will prevent other children experiencing adverse drug reacdons. . Regrettably Paediatricians and other doctors caring for children seem to have a poor record for completing Yellow Cards although there is no hard evidence for this. To improve our knowledge and understanding of drug safety in children' we must have comPrehensive rePorting' A recent circulated self assessment bulletin on which the article is based to paediatricians in'\(ales is an intervention to improve rePorting of adverse side effects ofdrugs given to children' en_US
dc.subject Iatrogenic diseas en_US
dc.subject Drugs en_US
dc.subject Children en_US
dc.subject Yellow Card Schem en_US
dc.title Drug related Iatrogenic disease: the specal vulnerability of children en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account